Genomic instability of surgical sample and cancer-initiating cell lines from human glioblastoma

Frontiers in Bioscience

Volumn 17, Issue 4, 2012, Pages 1469-1479

  Perez Garcia, Arantxa ^a   Carrion Navarro, Josefa ^a,b   Bosch Fortea, Minerva ^a   Lazaro Ibanez, Elisa ^a   Prat Acin, Ricardo ^c   Ayuso Sacido, Angel ^a,b  

^a CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Cancer stem cells; Genomic instability; Glioblastoma; Glioma; Review

Indexed keywords

BRAIN TUMOR; GENOMIC INSTABILITY; GLIOBLASTOMA; HUMAN; PATHOLOGY; REVIEW;

BRAIN NEOPLASMS; GENOMIC INSTABILITY; GLIOBLASTOMA; HUMANS;

EID: 84859234515     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3998     Document Type: Article

References (83)

1. F. B. Furnari, T. Fenton, R. M. Bachoo, A. Mukasa, J. M. Stommel, A. Stegh, W. C. Hahn, K. L. Ligon, D. N. Louis, C. Brennan, L. Chin, R. A. DePinho and W. K. Cavenee: Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21 (21), 2683-710 (2007). (Pubitemid 350070717)
2. R. Stupp, W. P. Mason, M. J. van den Bent, M. Weller, B. Fisher, M. J. Taphoorn, K. Belanger, A. A. Brandes, C. Marosi, U. Bogdahn, J. Curschmann, R. C. Janzer, S. K. Ludwin, T. Gorlia, A. Allgeier, D. Lacombe, J. G. Cairncross, E. Eisenhauer and R. O. Mirimanoff: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352 (10), 987-96 (2005). (Pubitemid 40349501)
3. C. Brennan, H. Momota, D. Hambardzumyan, T. Ozawa, A. Tandon, A. Pedraza and E. Holland: Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations. PLoS One 4 (11), e7752 (2009).
4. S. K. Singh, I. D. Clarke, M. Terasaki, V. E. Bonn, C. Hawkins, J. Squire and P. B. Dirks: Identification of a cancer stem cell in human brain tumors. Cancer Res 63 (18), 5821-8 (2003). (Pubitemid 37187480)
5. S. K. Singh, C. Hawkins, I. D. Clarke, J. A. Squire, J. Bayani, T. Hide, R. M. Henkelman, M. D. Cusimano and P. B. Dirks: Identification of human brain tumour initiating cells. Nature 432 (7015), 396-401 (2004). (Pubitemid 39551674)
6. H. D. Hemmati, I. Nakano, J. A. Lazareff, M. Masterman-Smith, D. H. Geschwind, M. Bronner-Fraser and H. I. Kornblum: Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A 100 (25), 15178-83 (2003). (Pubitemid 37518036)
7. K. Harada, T. Nishizaki, S. Ozaki, H. Kubota, H. Ito and K. Sasaki: Intratumoral cytogenetic heterogeneity detected by comparative genomic hybridization and laser scanning cytometry in human gliomas. Cancer Res 58 (20), 4694-700 (1998). (Pubitemid 28480637)
8. S. Sathornsumetee and J. N. Rich: Designer therapies for glioblastoma multiforme. Ann N Y Acad Sci 1142, 108-32 (2008).
9. H. Ohgaki, P. Dessen, B. Jourde, S. Horstmann, T. Nishikawa, P. L. Di Patre, C. Burkhard, D. Schuler, N. M. Probst-Hensch, P. C. Maiorka, N. Baeza, P. Pisani, Y. Yonekawa, M. G. Yasargil, U. M. Lutolf and P. Kleihues: Genetic pathways to glioblastoma: a population-based study. Cancer Res 64 (19), 6892-9 (2004). (Pubitemid 39330996)
10. H. Ohgaki and P. Kleihues: Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 64 (6), 479-89 (2005). (Pubitemid 40781150)
11. S. Godard, G. Getz, M. Delorenzi, P. Farmer, H. Kobayashi, I. Desbaillets, M. Nozaki, A. C. Diserens, M. F. Hamou, P. Y. Dietrich, L. Regli, R. C. Janzer, P. Bucher, R. Stupp, N. de Tribolet, E. Domany and M. E. Hegi: Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes. Cancer Res 63 (20), 6613-25 (2003). (Pubitemid 37322939)
12. M. Furuta, R. J. Weil, A. O. Vortmeyer, S. Huang, J. Lei, T. N. Huang, Y. S. Lee, D. A. Bhowmick, I. A. Lubensky, E. H. Oldfield and Z. Zhuang: Protein patterns and proteins that identify subtypes of glioblastoma multiforme. Oncogene 23 (40), 6806-14 (2004). (Pubitemid 39280012)
13. J. Li, C. Yen, D. Liaw, K. Podsypanina, S. Bose, S. I. Wang, J. Puc, C. Miliaresis, L. Rodgers, R. McCombie, S. H. Bigner, B. C. Giovanella, M. Ittmann, B. Tycko, H. Hibshoosh, M. H. Wigler and R. Parsons: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275 (5308), 1943-7 (1997). (Pubitemid 27148818)
14. H. S. Phillips, S. Kharbanda, R. Chen, W. F. Forrest, R. H. Soriano, T. D. Wu, A. Misra, J. M. Nigro, H. Colman, L. Soroceanu, P. M. Williams, Z. Modrusan, B. G. Feuerstein and K. Aldape: Molecular subclasses of highgrade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9 (3), 157-73 (2006). (Pubitemid 43357943)
15. R. G. Verhaak, K. A. Hoadley, E. Purdom, V. Wang, Y. Qi, M. D. Wilkerson, C. R. Miller, L. Ding, T. Golub, J. P. Mesirov, G. Alexe, M. Lawrence, M. O'Kelly, P. Tamayo, B. A. Weir, S. Gabriel, W. Winckler, S. Gupta, L. Jakkula, H. S. Feiler, J. G. Hodgson, C. D. James, J. N. Sarkaria, C. Brennan, A. Kahn, P. T. Spellman, R. K. Wilson, T. P. Speed, J. W. Gray, M. Meyerson, G. Getz, C. M. Perou and D. N. Hayes: Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17 (1), 98-110.
16. H. S. Gunther, N. O. Schmidt, H. S. Phillips, D. Kemming, S. Kharbanda, R. Soriano, Z. Modrusan, H. Meissner, M. Westphal and K. Lamszus: Glioblastomaderived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria. Oncogene 27 (20), 2897-909 (2008). (Pubitemid 351620450)
17. C. Lottaz, D. Beier, K. Meyer, P. Kumar, A. Hermann, J. Schwarz, M. Junker, P. J. Oefner, U. Bogdahn, J. Wischhusen, R. Spang, A. Storch and C. P. Beier: Transcriptional profiles of CD133+ and CD133- glioblastoma-derived cancer stem cell lines suggest different cells of origin. Cancer Res 70 (5), 2030-40 (2010).
18. B. Klink, B. Schlingelhof, M. Klink, K. Stout-Weider, S. Patt and E. Schrock: Glioblastomas with oligodendroglial component - common origin of the different histological parts and genetic subclassification. Anal Cell Pathol (Amst) 33 (1), 37-54 (2010).
19. A. Shiras, S. T. Chettiar, V. Shepal, G. Rajendran, G. R. Prasad and P. Shastry: Spontaneous transformation of human adult nontumorigenic stem cells to cancer stem cells is driven by genomic instability in a human model of glioblastoma. Stem Cells 25 (6), 1478-89 (2007). (Pubitemid 47106016)
20. B. W. Purow, R. M. Haque, M. W. Noel, Q. Su, M. J. Burdick, J. Lee, T. Sundaresan, S. Pastorino, J. K. Park, I. Mikolaenko, D. Maric, C. G. Eberhart and H. A. Fine: Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. Cancer Res 65 (6), 2353-63 (2005). (Pubitemid 40490146)
21. X. Fan, I. Mikolaenko, I. Elhassan, X. Ni, Y. Wang, D. Ball, D. J. Brat, A. Perry and C. G. Eberhart: Notch1 and notch2 have opposite effects on embryonal brain tumor growth. Cancer Res 64 (21), 7787-93 (2004). (Pubitemid 39446911)
22. X. Fan, L. Khaki, T. S. Zhu, M. E. Soules, C. E. Talsma, N. Gul, C. Koh, J. Zhang, Y. M. Li, J. Maciaczyk, G. Nikkhah, F. Dimeco, S. Piccirillo, A. L. Vescovi and C. G. Eberhart: NOTCH pathway blockade depletes CD133- positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells 28 (1), 5-16 (2010).
23. E. E. Bar, A. Chaudhry, A. Lin, X. Fan, K. Schreck, W. Matsui, S. Piccirillo, A. L. Vescovi, F. DiMeco, A. Olivi and C. G. Eberhart: Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells 25 (10), 2524-33 (2007). (Pubitemid 47582744)
24. V. Clement, P. Sanchez, N. de Tribolet, I. Radovanovic and A. Ruiz i Altaba: HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell selfrenewal, and tumorigenicity. Curr Biol 17 (2), 165-72 (2007). (Pubitemid 46107823)
25. J. Massague: TGFbeta in Cancer. Cell, 134 (2), 215-30 (2008).
26. A. Bruna, R. S. Darken, F. Rojo, A. Ocana, S. Penuelas, A. Arias, R. Paris, A. Tortosa, J. Mora, J. Baselga and J. Seoane: High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene. Cancer Cell 11 (2), 147-60 (2007). (Pubitemid 46209848)
27. H. Ikushima, T. Todo, Y. Ino, M. Takahashi, K. Miyazawa and K. Miyazono: Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors. Cell Stem Cell 5 (5), 504-.
28. S. Penuelas, J. Anido, R. M. Prieto-Sanchez, G. Folch, I. Barba, I. Cuartas, D. Garcia-Dorado, M. A. Poca, J. Sahuquillo, J. Baselga and J. Seoane: TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. Cancer Cell 15 (4), 315-27 (2009).
29. J. Anido, A. Saez-Borderias, A. Gonzalez-Junca, L. Rodon, G. Folch, M. A. Carmona, R. M. Prieto-Sanchez, I. Barba, E. Martinez-Saez, L. Prudkin, I. Cuartas, C. Raventos, F. Martinez-Ricarte, M. A. Poca, D. Garcia- Dorado, M. M. Lahn, J. M. Yingling, J. Rodon, J. Sahuquillo, J. Baselga and J. Seoane: TGF-beta Receptor Inhibitors Target the CD44 (high)/Id1 (high) Glioma- Initiating Cell Population in Human Glioblastoma. Cancer Cell 18 (6), 655-68.
30. J. M. Leonard, H. Ye, C. Wetmore and L. M. Karnitz: Sonic Hedgehog signaling impairs ionizing radiationinduced checkpoint activation and induces genomic instability. J Cell Biol 183 (3), 385-91 (2008).
31. G. S. Baia, S. Stifani, E. T. Kimura, M. W. McDermott, R. O. Pieper and A. Lal: Notch activation is associated with tetraploidy and enhanced chromosomal instability in meningiomas. Neoplasia 10 (6), 604-12 (2008). (Pubitemid 351770304)
32. M. Bredel, D. M. Scholtens, A. K. Yadav, A. A. Alvarez, J. J. Renfrow, J. P. Chandler, I. L. Yu, M. S. Carro, F. Dai, M. J. Tagge, R. Ferrarese, C. Bredel, H. S. Phillips, P. J. Lukac, P. A. Robe, A. Weyerbrock, H. Vogel, S. Dubner, B. Mobley, X. He, A. C. Scheck, B. I. Sikic, K. D. Aldape, A. Chakravarti and G. R. t. Harsh: NFKBIA deletion in glioblastomas. N Engl J Med 364 (7), 627-37.
33. L. Li, A. Dutra, E. Pak, J. E. Labrie 3rd, R. M. Gerstein, P. P. Pandolfi, L. D. Recht and A. H. Ross: EGFRvIII expression and PTEN loss synergistically induce chromosomal instability and glial tumors. Neuro Oncol 11 (1), 9-21 (2009).
34. D. Gisselsson, L. Pettersson, M. Hoglund, M. Heidenblad, L. Gorunova, J. Wiegant, F. Mertens, P. Dal Cin, F. Mitelman and N. Mandahl: Chromosomal breakagefusion- bridge events cause genetic intratumor heterogeneity. Proc Natl Acad Sci U S A 97 (10), 5357-62 (2000). (Pubitemid 30313723)
35. C. Glanz, J. Rebetz, Y. Stewenius, A. Persson, E. Englund, N. Mandahl, F. Mertens, L. G. Salford, B. Widegren, X. Fan and D. Gisselsson: Genetic intratumour heterogeneity in high-grade brain tumours is associated with telomere-dependent mitotic instability. Neuropathol Appl Neurobiol 33 (4), 440-54 (2007). (Pubitemid 47037892)
36. J. Karlseder, A. Smogorzewska and T. de Lange: Senescence induced by altered telomere state, not telomere loss. Science 295 (5564), 2446-9 (2002). (Pubitemid 34270257)
37. B. Zhivotovsky and G. Kroemer: Apoptosis and genomic instability. Nat Rev Mol Cell Biol 5 (9), 752-62 (2004). (Pubitemid 39208184)
38. T. H. Bestor: Cloning of a mammalian DNA methyltransferase. Gene 74 (1), 9-12 (1988). (Pubitemid 19069347)
39. M. Okano, S. Xie and E. Li: Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat Genet 19 (3), 219-20 (1998). (Pubitemid 28309328)
40. E. Li, C. Beard and R. Jaenisch: Role for DNA methylation in genomic imprinting. Nature 366 (6453), 362-5 (1993). (Pubitemid 23349366)
41. A. Eden, F. Gaudet, A. Waghmare and R. Jaenisch: Chromosomal instability and tumors promoted by DNA hypomethylation. Science 300 (5618), 455 (2003). (Pubitemid 36444319)
42. B. M. Turner: Reading signals on the nucleosome with a new nomenclature for modified histones. Nat Struct Mol Biol 12 (2), 110-2 (2005).
43. D. P. Bartel: MicroRNAs: target recognition and regulatory functions. Cell 136 (2), 215-33 (2009).
44. B. Cadieux, T. T. Ching, S. R. VandenBerg and J. F. Costello: Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation. Cancer Res 66 (17), 8469-76 (2006). (Pubitemid 44449159)
45. F. Gaudet, J. G. Hodgson, A. Eden, L. Jackson-Grusby, J. Dausman, J. W. Gray, H. Leonhardt and R. Jaenisch: Induction of tumors in mice by genomic hypomethylation. Science 300 (5618), 489-92 (2003). (Pubitemid 36444330)
46. M. Fanelli, S. Caprodossi, L. Ricci-Vitiani, A. Porcellini, F. Tomassoni-Ardori, S. Amatori, F. Andreoni, M. Magnani, R. De Maria, A. Santoni, S. Minucci and P. G. Pelicci: Loss of pericentromeric DNA methylation pattern in human glioblastoma is associated with altered DNA methyltransferases expression and involves the stem cell compartment. Oncogene 27 (3), 358-65 (2008).
47. J. F. Costello, M. S. Berger, H. S. Huang and W. K. Cavenee: Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation. Cancer Res 56 (10), 2405-10 (1996). (Pubitemid 26154090)
48. N. Baeza, M. Weller, Y. Yonekawa, P. Kleihues and H. Ohgaki: PTEN methylation and expression in glioblastomas. Acta Neuropathol 106 (5), 479-85 (2003). (Pubitemid 37265852)
49. M. Nakamura, Y. Yonekawa, P. Kleihues and H. Ohgaki: Promoter hypermethylation of the RB1 gene in glioblastomas. Lab Invest 81 (1), 77-82 (2001). (Pubitemid 32108641)
50. V. J. Amatya, U. Naumann, M. Weller and H. Ohgaki: TP53 promoter methylation in human gliomas. Acta Neuropathol 110 (2), 178-84 (2005). (Pubitemid 41245207)
51. T. Watanabe, H. Yokoo, M. Yokoo, Y. Yonekawa, P. Kleihues and H. Ohgaki: Concurrent inactivation of RB1 and TP53 pathways in anaplastic oligodendrogliomas. J Neuropathol Exp Neurol 60 (12), 1181-9 (2001). (Pubitemid 33117098)
52. M. J. Bello and J. A. Rey: The p53/Mdm2/p14ARF cell cycle control pathway genes may be inactivated by genetic and epigenetic mechanisms in gliomas. Cancer Genet Cytogenet 164 (2), 172-3 (2006). (Pubitemid 43129767)
53. S. L. Gerson: MGMT: its role in cancer aetiology and cancer therapeutics. Nat Rev Cancer 4 (4), 296-307 (2004). (Pubitemid 38525285)
54. M. E. Hegi, A. C. Diserens, T. Gorlia, M. F. Hamou, N. de Tribolet, M. Weller, J. M. Kros, J. A. Hainfellner, W. Mason, L. Mariani, J. E. Bromberg, P. Hau, R. O. Mirimanoff, J. G. Cairncross, R. C. Janzer and R. Stupp: MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352 (10), 997-1003 (2005). (Pubitemid 40349502)
55. S. Everhard, G. Kaloshi, E. Criniere, A. Benouaich-Amiel, J. Lejeune, Y. Marie, M. Sanson, M. Kujas, K. Mokhtari, K. Hoang-Xuan, J. Y. Delattre and J. Thillet: MGMT methylation: a marker of response to temozolomide in lowgrade gliomas. Ann Neurol, 60 (6), 740-3 (2006). (Pubitemid 46048490)
56. C. G. A. R. Network: Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455 (7216), 1061-8 (2008).
57. T. Watanabe, Y. Katayama, A. Yoshino, K. Yachi, T. Ohta, A. Ogino, C. Komine and T. Fukushima: Aberrant hypermethylation of p14ARF and O6-methylguanine-DNA methyltransferase genes in astrocytoma progression. Brain Pathol 17 (1), 5-10 (2007).
58. R. Martinez, F. Setien, C. Voelter, S. Casado, M. P. Quesada, G. Schackert and M. Esteller: CpG island promoter hypermethylation of the pro-apoptotic gene caspase-8 is a common hallmark of relapsed glioblastoma multiforme. Carcinogenesis 28 (6), 1264-8 (2007). (Pubitemid 47062686)
59. V. Hayry, M. Tanner, T. Blom, O. Tynninen, A. Roselli, M. Ollikainen, H. Sariola, K. Wartiovaara and N. N. Nupponen: Copy number alterations of the polycomb gene BMI1 in gliomas. Acta Neuropathol 116 (1), 97-102 (2008).
60. A. K. Lucio-Eterovic, M. A. Cortez, E. T. Valera, F. J. Motta, R. G. Queiroz, H. R. Machado, C. G. Carlotti Jr., L. Neder, C. A. Scrideli and L. G. Tone: Differential expression of 12 histone deacetylase (HDAC) genes in astrocytomas and normal brain tissue: class II and IV are hypoexpressed in glioblastomas. BMC Cancer 8, 243 (2008).
61. M. S. Nicoloso and G. A. Calin: MicroRNA involvement in brain tumors: from bench to bedside. Brain Pathol 18 (1), 122-9 (2008).
62. S. A. Ciafre, S. Galardi, A. Mangiola, M. Ferracin, C. G. Liu, G. Sabatino, M. Negrini, G. Maira, C. M. Croce and M. G. Farace: Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 334 (4), 1351-8 (2005). (Pubitemid 41074723)
63. J. A. Chan, A. M. Krichevsky and K. S. Kosik: MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65 (14), 6029-33 (2005). (Pubitemid 40994386)
64. J. Godlewski, M. O. Nowicki, A. Bronisz, S. Williams, A. Otsuki, G. Nuovo, A. Raychaudhury, H. B. Newton, E. A. Chiocca and S. Lawler: Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res 68 (22), 9125-30 (2008).
65. J. Silber, D. A. Lim, C. Petritsch, A. I. Persson, A. K. Maunakea, M. Yu, S. R. Vandenberg, D. G. Ginzinger, C. D. James, J. F. Costello, G. Bergers, W. A. Weiss, A. Alvarez- Buylla and J. G. Hodgson: miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 6, 14 (2008).
66. Y. Zhang, T. Chao, R. Li, W. Liu, Y. Chen, X. Yan, Y. Gong, B. Yin, B. Qiang, J. Zhao, J. Yuan and X. Peng: MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a. J Mol Med 87 (1), 43-51 (2009).
67. P. Sun, S. Xia, B. Lal, C. G. Eberhart, A. Quinones-Hinojosa, J. Maciaczyk, W. Matsui, F. Dimeco, S. M. Piccirillo, A. L. Vescovi and J. Laterra: DNER, an epigenetically modulated gene, regulates glioblastoma-derived neurosphere cell differentiation and tumor propagation. Stem Cells 27 (7), 1473-86 (2009).
68. J. Lee, M. J. Son, K. Woolard, N. M. Donin, A. Li, C. H. Cheng, S. Kotliarova, Y. Kotliarov, J. Walling, S. Ahn, M. Kim, M. Totonchy, T. Cusack, C. Ene, H. Ma, Q. Su, J. C. Zenklusen, W. Zhang, D. Maric and H. A. Fine: Epigeneticmediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell 13 (1), 69-80 (2008). (Pubitemid 350309742)
69. A. Waha, J. Felsberg, W. Hartmann, A. von dem Knesebeck, T. Mikeska, S. Joos, M. Wolter, A. Koch, P. S. Yan, E. Endl, O. D. Wiestler, G. Reifenberger and T. Pietsch: Epigenetic downregulation of mitogen-activated protein kinase phosphatase MKP-2 relieves its growth suppressive activity in glioma cells. Cancer Res 70 (4), 1689-99.
70. J. T. Huse, C. Brennan, D. Hambardzumyan, B. Wee, J. Pena, S. H. Rouhanifard, C. Sohn-Lee, C. le Sage, R. Agami, T. Tuschl and E. C. Holland: The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev 23 (11), 1327-37 (2009).
71. R. Galli, E. Binda, U. Orfanelli, B. Cipelletti, A. Gritti, S. De Vitis, R. Fiocco, C. Foroni, F. Dimeco and A. Vescovi: Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64 (19), 7011-21 (2004). (Pubitemid 39331011)
72. T. N. Ignatova, V. G. Kukekov, E. D. Laywell, O. N. Suslov, F. D. Vrionis and D. A. Steindler: Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 39 (3), 193-206 (2002).
73. X. Yuan, J. Curtin, Y. Xiong, G. Liu, S. Waschsmann-Hogiu, D. L. Farkas, K. L. Black and J. S. Yu: Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 23 (58), 9392-400 (2004). (Pubitemid 40069671)
74. J. Lee, S. Kotliarova, Y. Kotliarov, A. Li, Q. Su, N. M. Donin, S. Pastorino, B. W. Purow, N. Christopher, W. Zhang, J. K. Park and H. A. Fine: Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serumcultured cell lines. Cancer Cell 9 (5), 391-403 (2006). (Pubitemid 43668737)
75. P. C. De Witt Hamer, A. A. Van Tilborg, P. P. Eijk, P. Sminia, D. Troost, C. J. Van Noorden, B. Ylstra and S. Leenstra: The genomic profile of human malignant glioma is altered early in primary cell culture and preserved in spheroids. Oncogene 27 (14), 2091-6 (2008). (Pubitemid 351442747)
76. S. M. Pollard, K. Yoshikawa, I. D. Clarke, D. Danovi, S. Stricker, R. Russell, J. Bayani, R. Head, M. Lee, M. Bernstein, J. A. Squire, A. Smith and P. Dirks: Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 4 (6), 568-80 (2009).
77. Y. Sun, S. Pollard, L. Conti, M. Toselli, G. Biella, G. Parkin, L. Willatt, A. Falk, E. Cattaneo and A. Smith: Longterm tripotent differentiation capacity of human neural stem (NS) cells in adherent culture. Mol Cell Neurosci 38 (2), 245- 58 (2008).
78. L. Conti, S. M. Pollard, T. Gorba, E. Reitano, M. Toselli, G. Biella, Y. Sun, S. Sanzone, Q. L. Ying, E. Cattaneo and A. Smith: Niche-independent symmetrical self-renewal of a mammalian tissue stem cell. PLoS Biol 3 (9), e283 (2005).
79. M. Csete: Oxygen in the cultivation of stem cells. Ann N Y Acad Sci 1049, 1-8 (2005). (Pubitemid 40967569)
80. J. Kolenda, S. S. Jensen, C. Aaberg-Jessen, K. Christensen, C. Andersen, N. Brunner and B. W. Kristensen: Effects of hypoxia on expression of a panel of stem cell and chemoresistance markers in glioblastoma-derived spheroids. J Neurooncol 103(1):43-58 (2011).
81. J. Bartkova, P. Hamerlik, M. T. Stockhausen, J. Ehrmann, A. Hlobilkova, H. Laursen, O. Kalita, Z. Kolar, H. S. Poulsen, H. Broholm, J. Lukas and J. Bartek: Replication stress and oxidative damage contribute to aberrant constitutive activation of DNA damage signalling in human gliomas. Oncogene 29 (36), 5095-102 (2010).
82. J. Bartek, J. Bartkova and J. Lukas: DNA damage signalling guards against activated oncogenes and tumour progression. Oncogene 26 (56), 7773-9 (2007). (Pubitemid 350242463)
83. T. D. Halazonetis, V. G. Gorgoulis and J. Bartek: An oncogene-induced DNA damage model for cancer development. Science 319 (5868), 1352-5 (2008). (Pubitemid 351354863)